BSE Live
Oct 27, 14:26Prev. Close
1677.85
Open Price
1686.20
Bid Price (Qty.)
1684.00 (48)
Offer Price (Qty.)
1685.00 (10)
NSE Live
Prev. Close
Open Price
Bid Price (Qty.)
()
Offer Price (Qty.)
()
| Balance Sheet of Fredun Pharmaceuticals Limited (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| EQUITIES AND LIABILITIES | ||||||
| SHAREHOLDER'S FUNDS | ||||||
| Equity Share Capital | 4.72 | 4.70 | 4.53 | 4.43 | 3.99 | |
| Total Share Capital | 4.72 | 4.70 | 4.53 | 4.43 | 3.99 | |
| Reserves and Surplus | 136.68 | 115.20 | 91.84 | 63.63 | 39.08 | |
| Total Reserves and Surplus | 136.68 | 115.20 | 91.84 | 63.63 | 39.08 | |
| Total Shareholders Funds | 141.40 | 121.47 | 96.38 | 68.06 | 43.07 | |
| NON-CURRENT LIABILITIES | ||||||
| Long Term Borrowings | 9.61 | 12.80 | 48.93 | 42.04 | 29.11 | |
| Deferred Tax Liabilities [Net] | 4.48 | 4.14 | 3.84 | 1.43 | 1.38 | |
| Other Long Term Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long Term Provisions | 3.83 | 2.37 | 1.96 | 1.71 | 1.60 | |
| Total Non-Current Liabilities | 17.93 | 19.30 | 54.74 | 45.18 | 32.09 | |
| CURRENT LIABILITIES | ||||||
| Short Term Borrowings | 156.79 | 92.71 | 37.60 | 10.73 | 10.53 | |
| Trade Payables | 144.76 | 62.95 | 59.34 | 48.62 | 59.96 | |
| Other Current Liabilities | 25.77 | 11.17 | 9.23 | 14.41 | 15.97 | |
| Short Term Provisions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Current Liabilities | 327.32 | 166.83 | 106.17 | 73.75 | 86.46 | |
| Total Capital And Liabilities | 486.65 | 307.60 | 257.28 | 186.99 | 161.62 | |
| ASSETS | ||||||
| NON-CURRENT ASSETS | ||||||
| Tangible Assets | 52.14 | 46.15 | 38.63 | 32.28 | 30.32 | |
| Intangible Assets | 0.43 | 0.42 | 0.31 | 0.06 | 0.03 | |
| Capital Work-In-Progress | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Fixed Assets | 52.57 | 46.57 | 38.93 | 32.34 | 30.35 | |
| Non-Current Investments | 0.76 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Deferred Tax Assets [Net] | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long Term Loans And Advances | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Non-Current Assets | 5.79 | 3.82 | 2.13 | 2.00 | 1.18 | |
| Total Non-Current Assets | 59.12 | 50.40 | 41.07 | 34.34 | 31.54 | |
| CURRENT ASSETS | ||||||
| Current Investments | 0.75 | 0.81 | 0.31 | 0.06 | 0.06 | |
| Inventories | 239.89 | 175.00 | 150.12 | 46.46 | 67.57 | |
| Trade Receivables | 177.12 | 64.85 | 34.56 | 90.27 | 41.08 | |
| Cash And Cash Equivalents | 4.82 | 1.35 | 3.44 | 2.07 | 1.13 | |
| Short Term Loans And Advances | 0.47 | 0.25 | 0.15 | 0.09 | 0.73 | |
| OtherCurrentAssets | 4.49 | 14.95 | 27.63 | 13.70 | 19.52 | |
| Total Current Assets | 427.53 | 257.20 | 216.21 | 152.65 | 130.08 | |
| Total Assets | 486.65 | 307.60 | 257.28 | 186.99 | 161.62 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| CONTINGENT LIABILITIES, COMMITMENTS | ||||||
| Contingent Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| CIF VALUE OF IMPORTS | ||||||
| Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Stores, Spares And Loose Tools | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Trade/Other Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Capital Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| EXPENDITURE IN FOREIGN EXCHANGE | ||||||
| Expenditure In Foreign Currency | 0.00 | 0.90 | 0.53 | 0.78 | 0.74 | |
| REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | ||||||
| Dividend Remittance In Foreign Currency | -- | -- | -- | -- | -- | |
| EARNINGS IN FOREIGN EXCHANGE | ||||||
| FOB Value Of Goods | -- | 77.71 | 62.03 | -- | -- | |
| Other Earnings | -- | -- | -- | 73.61 | 44.18 | |
| BONUS DETAILS | ||||||
| Bonus Equity Share Capital | -- | -- | -- | -- | -- | |
| NON-CURRENT INVESTMENTS | ||||||
| Non-Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Non-Current Investments Unquoted Book Value | -- | 0.00 | 0.00 | 0.00 | 0.00 | |
| CURRENT INVESTMENTS | ||||||
| Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Current Investments Unquoted Book Value | -- | 0.81 | 0.31 | 0.06 | 0.06 |
31.07.2025
Fredun Pharmace Standalone June 2025 Net Sales at Rs 119.40 crore, up 54% Y-o-Y
24.06.2025
Fredun Pharmace Standalone March 2025 Net Sales at Rs 165.44 crore, up 40.16% Y-o-Y
05.02.2025
Fredun Pharmace Standalone December 2024 Net Sales at Rs 101.84 crore, up 17.52% Y-o-Y
30.07.2024
Fredun Pharmace Standalone June 2024 Net Sales at Rs 77.54 crore, up 26.64% Y-o-Y
31.07.2025
Fredun Pharmace Standalone June 2025 Net Sales at Rs 119.40 crore, up 54% Y-o-Y
24.06.2025
Fredun Pharmace Standalone March 2025 Net Sales at Rs 165.44 crore, up 40.16% Y-o-Y
05.02.2025
Fredun Pharmace Standalone December 2024 Net Sales at Rs 101.84 crore, up 17.52% Y-o-Y
30.07.2024
Fredun Pharmace Standalone June 2024 Net Sales at Rs 77.54 crore, up 26.64% Y-o-Y